Abstract
Mitophagy, the elimination of mitochondria via the autophagy-lysosome pathway, is essential for the maintenance of cellular homeostasis. The best characterised mitophagy pathway is mediated by stabilisation of the protein kinase PINK1 and recruitment of the ubiquitin ligase Parkin to damaged mitochondria. Ubiquitinated mitochondrial surface proteins are recognised by autophagy receptors including NDP52 which initiate the formation of an autophagic vesicle around the mitochondria. Damaged mitochondria also generate reactive oxygen species (ROS) which have been proposed to act as a signal for mitophagy, however the mechanism of ROS sensing is unknown. Here we found that oxidation of NDP52 is essential for the efficient PINK1/Parkin-dependent mitophagy. We identified redox-sensitive cysteine residues involved in disulphide bond formation and oligomerisation of NDP52 on damaged mitochondria. Oligomerisation of NDP52 facilitates the recruitment of autophagy machinery for rapid mitochondrial degradation. We propose that redox sensing by NDP52 allows mitophagy to function as a mechanism of oxidative stress response.
Original language | English |
---|---|
Pages (from-to) | e111372 |
Journal | EMBO Journal |
Early online date | 14 Dec 2022 |
DOIs | |
Publication status | E-pub ahead of print - 14 Dec 2022 |
Bibliographical note
Funding Information:We are grateful to Hanna Salmonowicz for graphical design; Glyn Nelson and Newcastle Bioimaging Unit for imaging assistance. This study was supported by Fellowships from Uehara Memorial Foundation and the International Medical Research Foundation to TK; FEDER (2018/D/LD/MC/8) to YR‐R; a Marie Skłodowska‐Curie MSCA Postdoctoral Fellowship to EA (101062916); a Wellcome Trust Fellowship (218547/Z/19/Z) to BC; the Austrian Science Fund (FWF SFB F79) to SM; NHMRC (GNT1106471, GNT1160315) and Australian Research Council (FT1601100063, DP200100347) to ML; BBSRC (BB/M023389/1) and BBSRC (BB/R008167/2) grants to VIK; Royal Society‐Newton Mobility Grant (IEC\NSFC\170125) to VIK and XC.
Publisher Copyright:
© 2022 The Authors. Published under the terms of the CC BY 4.0 license.